Effective January 18, 2016, the Board of Directors of IntelGenx Technologies Corp. has appointed Robert J. Bechard to serve as Vice President, Corporate Development and Nadine Paiement to serve as Vice President, Research and Development of IntelGenx Corp. Robert Bechard has over 20 years of experience in the biopharmaceutical industry having worked for two lifescience venture capital funds, a pharmaceutical R&D management company and as a consultant to the biotech industry.

Most recently, from March 2014 to January 2016, Mr. Bechard was Chief Business Officer for InSymbiosis Inc. where he was also responsible for managing InSymbiosis Capital, a lifescience venture capital fund. Prior to that, from November 2009 to March 2014 he worked as an independent consultant to private companies providing assistance with corporate strategy, business development as well as fundraising.